ARCT Q4 2018 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-41.7% YoY

Gross Profit

$3M36.0% margin

Operating Income

-$711,000-9.4% margin

Net Income

-$1M-13.3% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+121.4%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$506,000

Balance Sheet

Total Assets

$44M

Total Liabilities

$31M

Stockholders' Equity

$14M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$13M	-41.7%
Gross Profit	$3M	$9M	-68.4%
Operating Income	-$711,000	-$144,000	-393.8%
Net Income	-$1M	-$1M	+11.0%